Oracle Head & Neck Cancer UK’s Post

📢 Oracle Head & Neck Cancer UK Launches £55,000 Small Grants Programme 📢 We’re thrilled to announce the launch of our Small Grants Programme aimed at advancing research to improve outcomes for head and neck cancer patients. With a total funding pool of £55,000, we’ll be supporting 1-3 innovative research projects that have the potential to translate into clinical practice, benefit patients directly, or lay the groundwork for future large-scale studies. We’re encouraging interdisciplinary collaboration, welcoming proposals from allied health professionals and researchers working in the following areas: 🔬 Early detection and diagnosis 💡 Novel treatment approaches 🏥 Addressing health inequalities 🌟 Improving patient experience and quality of life Applications are open until 6 December 2024, with successful projects announced in February 2025. Rozlyn Redd, Director of Delivery and Impact, says: “We are excited to provide funding for innovative projects that will directly impact patient outcomes, driving real advancements in the treatment and care of head and neck cancer patients.” For more information and to apply, visit: 🔗 https://loom.ly/X_IUoDI Let’s continue pushing the boundaries of research and patient care! 💙 #ResearchFunding #HeadAndNeckCancer #Innovation #PatientCare #OracleHNC #HealthcareResearch

📢 Oracle Head & Neck Cancer UK Launches £55,000 Small Grants Programme 📢 We’re thrilled to announce the launch of our Small Grants Programme aimed at advancing research to improve outcomes for head and neck cancer patients. With a total funding pool of £55,000, we’ll be supporting 1-3 innovative research projects that have the potential to translate into clinical practice, benefit patients directly, or lay the groundwork for future large-scale studies. We’re encouraging interdisciplinary collaboration, welcoming proposals from allied health professionals and researchers working in the following areas: 🔬 Early detection and diagnosis 💡 Novel treatment approaches 🏥 Addressing health inequalities 🌟 Improving patient experience and quality of life Applications are open until 6 December 2024, with successful projects announced in February 2025. Rozlyn Redd, Director of Delivery and Impact, says: “We are excited to provide funding for innovative projects that will directly impact patient outcomes, driving real advancements in the treatment and care of head and neck cancer patients.” For more information and to apply, visit: 🔗 https://loom.ly/X_IUoDI Let’s continue pushing the boundaries of research and patient care! 💙 #ResearchFunding #HeadAndNeckCancer #Innovation #PatientCare #OracleHNC #HealthcareResearch

ICMR's Role in Shaping Cancer Policies and Guidelines: Insights from Dr. Prashant Mathur" Join Dr. John J. Alapatt, Consultant in Surgical Oncology at MVR Cancer Centre and Research Institute, in conversation with Dr. Prashant Mathur, Head of ICMR-NCDIR, as they delve into the crucial role of cancer data in shaping national health policies and clinical guidelines. Discover how ICMR utilizes cancer registry data to inform healthcare decisions, the ongoing efforts to refine clinical guidelines, and the major projects ICMR has undertaken to strengthen cancer care in India. Dr. Mathur will also discuss the challenges faced in data collection and the steps being taken to address them. A must-watch for anyone interested in the intersection of cancer research, policy, and public health. #Oncology #CancerResearch #ICMR #HealthcarePolicy #MVRCCRI #CancerCare

Cancer Research UK (CRUK) has today published a survey detailing the experiences of the UK clinical research workforce over the previous 18 months.   The findings are concerning, with 74% of those surveyed saying it’s become harder to deliver research in a timely manner in the last 18 months. 69% told us it was more difficult to meet recruitment targets.   Insights from the survey build on those gleaned from Longer, Better Lives, our manifesto for cancer research and care, and also show that without intervention, we could be on the cusp of an exodus of talent.   We cannot accept this and it’s why Cancer Research UK is calling on policymakers to ensure that clinical research remains a priority issue for the post-election UK Government.   https://lnkd.in/efFrZxWR

🩺 Let's Celebrate Cancer Research Day! Cancer Research Day is a reminder of the incredible strides we've made in the fight against cancer, and the journey still ahead. Discovering new treatments and better diagnostics is a collaborative effort between scientists, healthcare professionals, and the unwavering strength of patients and their families. As someone who works with some of the brightest minds in Clinical Development, I witness first-hand the passion and determination behind every breakthrough. From early-stage trials in small Biotech firms to large-scale studies in Big Pharma, the collective effort is astounding. 🧬 The statistics speak volumes: In the UK alone, cancer survival rates have doubled in the last 40 years (Cancer Research UK). This progress wouldn't be possible without the relentless work from all sectors of the life sciences industry. Let's take a moment today to appreciate all those involved in this essential work. Please share in the comments—what inspires you about the advancements in cancer research? Or get in touch to discuss how we can drive future breakthroughs together. #CancerResearch #ClinicalDevelopment #LifeSciences

We’ve published our annual report and accounts, showcasing key milestones and successes achieved throughout the 2023/24 financial year. Some of these successes include: 🗞️ An innovative £42m prostate cancer screening trial, co-funded by us and Prostate Cancer UK to find ways of detecting the country’s most common male cancer earlier. 🗞️ Our research invests in foundational underpinning science, facilities, talent and capacity building across the health and care workforce which makes the country and science superpower. Our Clinical Research Network supported the recruitment of 44 first participants to global studies, and to 558 commercial international studies overall in 2023/24, representing an increase in both measures compared to 2022/23. 🗞️ In 2023/24 we launched our first NIHR ‘Challenge’ funding call, investing £50 million into research to tackle inequalities in maternity care. 🗞️ Following the results from an NIHR-funded study, the UK Government has approved the use of digital pathology to help speed up analysis of cancer screening samples. Read the full news story below: https://lnkd.in/eUWBaZVE #AnnualReport

What a year 2023-24 was for the NIHR (National Institute for Health and Care Research) and I really enjoyed working on this Annual Report with my great team. There's so many ways the NIHR is making a difference. Our foreword by Lucy Chappell and Gail Marzetti sets out how the NIHR is delivering: 👊 Impact: NIHR research saves lives and improves the quality of life of the public, enhancing resilience and productivity 🤗 Inclusion: NIHR research identifies areas of under-representation, builds research capacity with communities and researchers, and collaborates with the public to deliver evidence-based solutions that address health and care inequalities 🌟 Innovation: Health and care research powers the UK's life science sector and technical advantage 💰 Investment: NIHR research drives economic returns, inward investment and economic growth. For every £1 invested in NIHR research, society receives over £13 of returns Please do give the report a read and find out how we're improving the health & wealth of the nation through research!

Where does your state 🇺🇸 measure up? The states with the highest rates of new #lungcancer cases are: AR, KY, ME, MO, MS, NC, OH, OK, TN, and WV. I love my current home state of #TN, but we are in the “red zone” for highest # of new #lungcancer cases per year. If anyone needs help, our multi-disciplinary #lungcancer team Vanderbilt-Ingram Cancer is outstanding - with deep expertise in lung cancer screening, interventional pulmonary, management of early and late stage disease, tumor genomics, IO toxicity, and supportive care. We also have an affiliated U.S. Department of Veterans Affairs VA hospital (on the same campus as Vanderbilt University Medical Center) to serve those who served our country. Fabien Maldonado Travis Osterman Cathy Eng Heather Jackson #lungcancerawarenessmonth Ps: to check out the rate of new #LungCancer cases in your state, see: https://lnkd.in/e_TN53-N National Cancer Institute (NCI) American Association for Cancer Research American Society of Clinical Oncology (ASCO)

The Power of Clinical Trials in the Fight Against Cancer. Clinical trials are a beacon of hope for cancer patients worldwide. For over 20 years Calian has been providing high quality clinical research services. These trials play a critical role in developing new treatments, improving existing therapies and ultimately finding a cure. Here's why Clinical Trials Matter: 1. Innovative Treatments: Clinical trials give patients access to cutting-edge therapies that aren't available to the public yet. 2. Personalized Medicine: Trials help identify which treatments work best for specific types of cancer and individual patient profiles. 3. Advancing Science: Every participant contributes to scientific knowledge, paving the way for future breakthroughs. 4. Improving Outcomes: Many standard treatments today are available because of successful clinical trials in the past. My dear friend Sindy and former Calian colleague is currently participating in a clinical trial as part of her treatment journey and helping to advance medicine for future generations. Here is her story. #ClinicalTrials #CancerResearch

EACR – Conference: Cancer and Ageing 👉 The EACR Virtual Conference on Cancer and Ageing converges at the intersection of two critical fronts in healthcare. Ageing populations worldwide face an increased risk of cancer, making the exploration of this relationship pivotal for healthcare advancements. 🎯 This conference aims to illuminate the intricate dynamics between ageing and cancer, fostering interdisciplinary dialogue among researchers and clinicians. By understanding the biological dimensions of cancer in ageing populations, we aspire to drive innovations in prevention, diagnosis, and treatment strategies. Target audience: researchers, clinician scientists, industry representatives... 🖋 Deadline for registration: November 11, 2024 📅 December 3-4, 2024 ▶ https://lnkd.in/dgiGhZHJ European Association for Cancer Research (EACR)